A case of macrophage activation syndrome successfully treated with anakinra (Q40408368)

20 September 2017

A case of macrophage activation syndrome successfully treated with anakinra (English)

1 reference

macrophage activation syndrome

20 September 2017

1 reference

1 reference

1 reference

Alison Kelly

1

1 reference

PubMed ID

18825135

20 September 2017

Athimalaipet V Ramanan

series ordinal

2

1 reference

20 September 2017

30 September 2008

1 reference

Nature Clinical Practice Rheumatology

20 September 2017

1 reference

20 September 2017

4

1 reference

20 September 2017

11

1 reference

20 September 2017

615-620

1 reference

https://scigraph.springernature.com/pub.10.1038/ncprheum0919

20 September 2017

0 references

cites work

Recognition and management of macrophage activation syndrome in juvenile arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Macrophage activation syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Successful management of reactive haemophagocytic syndrome in systemic-onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

The German etanercept registry for treatment of juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0919

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0919

1 reference

PubMed ID

18825135

Dimensions Publication ID

20 September 2017

0 references

1 reference

PubMed ID

18825135